Howard Capital Management Group LLC Sells 5,315 Shares of iShares Biotechnology ETF $IBB

Howard Capital Management Group LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 13.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 33,512 shares of the financial services provider’s stock after selling 5,315 shares during the period. Howard Capital Management Group LLC’s holdings in iShares Biotechnology ETF were worth $4,838,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in IBB. Berger Financial Group Inc boosted its stake in iShares Biotechnology ETF by 2.7% during the 3rd quarter. Berger Financial Group Inc now owns 2,829 shares of the financial services provider’s stock valued at $408,000 after purchasing an additional 75 shares during the period. Martin & Co. Inc. TN lifted its holdings in shares of iShares Biotechnology ETF by 0.4% during the second quarter. Martin & Co. Inc. TN now owns 20,218 shares of the financial services provider’s stock worth $2,558,000 after buying an additional 79 shares during the last quarter. Choreo LLC boosted its position in shares of iShares Biotechnology ETF by 2.7% in the second quarter. Choreo LLC now owns 3,071 shares of the financial services provider’s stock valued at $389,000 after acquiring an additional 80 shares during the period. Signet Financial Management LLC grew its stake in shares of iShares Biotechnology ETF by 3.3% in the second quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock worth $326,000 after acquiring an additional 83 shares during the last quarter. Finally, Optimum Investment Advisors increased its position in iShares Biotechnology ETF by 2.6% during the second quarter. Optimum Investment Advisors now owns 3,345 shares of the financial services provider’s stock worth $423,000 after acquiring an additional 84 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.7%

NASDAQ:IBB opened at $172.03 on Friday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $174.40. The company has a fifty day moving average price of $165.31 and a 200 day moving average price of $146.80.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were given a dividend of $0.1831 per share. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, December 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.